Video Experimental Relacionado
Updated: Jul 5, 2025
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.0K
Tratamientos médicos, quirúrgicos y físicos para la enfermedad de Parkinson
Tom Foltynie1, Veronica Bruno2, Susan Fox3
1Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
Lancet (London, England)
|January 20, 2024
Resumen
El tratamiento de la enfermedad de Parkinson requiere un enfoque multidisciplinario, que aborde tanto los síntomas motores como los no motores. Las nuevas estrategias de reemplazo de dopamina y las terapias modificadoras de la enfermedad son cruciales para mejorar la calidad de vida de los pacientes.
Área de la Ciencia:
- Neurología
- Trastornos del movimiento
Sus antecedentes:
- La terapia de reemplazo de dopamina es fundamental para el tratamiento de la enfermedad de Parkinson (EP).
- Las fluctuaciones motoras y los movimientos discinéticos requieren diversas intervenciones médicas y quirúrgicas.
- Los síntomas no motores afectan significativamente la calidad de vida de los pacientes con EP.
Objetivo del estudio:
- Revisar las últimas pruebas para el tratamiento óptimo de la enfermedad de Parkinson.
- Esbozar un enfoque experto para las opciones de tratamiento con pruebas insuficientes.
- Para resaltar la necesidad de terapias modificadoras de la enfermedad para los síntomas refractarios.
Principales métodos:
- Revisión de la evidencia actual para el tratamiento de la enfermedad de Parkinson.
- Consenso de expertos sobre las estrategias de tratamiento.
- Centrarse en los enfoques de equipo multidisciplinario.
Principales resultados:
- Están surgiendo nuevos métodos de administración de dopamina.
- El manejo multidisciplinario es clave tanto para los síntomas motores como para los no motores.
- Necesidad urgente de terapias para prevenir síntomas incapacitantes como problemas de marcha, deterioro cognitivo y trastornos del habla.
Conclusiones:
- El tratamiento óptimo de la enfermedad de Parkinson integra las terapias de dopamina en evolución con el manejo integral de los síntomas motores y no motores.
- Las estrategias adaptadas y basadas en la evidencia son esenciales para las necesidades individuales de los pacientes.
- El desarrollo de terapias modificadoras de la enfermedad es crítico para los síntomas refractarios.
Videos de Conceptos Relacionados
01:24Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
01:15Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
01:37Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K